Contract Manufacturing, General

Mar 15, 2018
BioPharm International
A review of the latest investments in facilities, equipment, and acquisitions by biopharma contract service providers.
Feb 01, 2018
BioPharm International
Greater clarity on the application of existing regulations will accelerate development of cell and gene therapies.
Jan 26, 2018
By BioPharm International Editors
The company relocated its headquarters to Riverview, Florida.
Jan 26, 2018
By BioPharm International Editors
The contract development and manufacturing organization has invested £30-million (US$42 million) at its Dundalk, Ireland site to offer expanded clinical trial services.
Jan 26, 2018
By BioPharm International Editors
The companies will be integrated to form the newly-branded AGC Biologics, which will specialize in customized contract development and manufacturing organization services for the scale-up and cGMP manufacture of protein-based therapeutics.
Jan 24, 2018
By BioPharm International Editors
KBI Biopharma's acquisition of Elion Labs expands KBI's biophysical and analytical characterization capabilities.
Jan 23, 2018
By BioPharm International Editors
Paragon Bioservices will build a new cGMP facility in Maryland and expand its existing cGMP facility at the University of Maryland's BioPark.
Dec 14, 2017
By BioPharm International Editors
Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate (ADC) to clinical trials.
Dec 13, 2017
By BioPharm International Editors
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
Dec 06, 2017
By BioPharm International Editors
The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.
native1_300x100
lorem ipsum